Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 157

Similar articles for PubMed (Select 22971512)

1.
2.

Mutations in BRAF correlate with poor survival of colorectal cancers in Chinese population.

Liou JM, Wu MS, Shun CT, Chiu HM, Chen MJ, Chen CC, Wang HP, Lin JT, Liang JT.

Int J Colorectal Dis. 2011 Nov;26(11):1387-95. doi: 10.1007/s00384-011-1229-1. Epub 2011 May 7.

PMID:
21553007
3.

Gene mutations in epidermal growth factor receptor signaling network and their association with survival in Chinese patients with metastatic colorectal cancers.

Liao W, Liao Y, Zhou JX, Xie J, Chen J, Huang W, Luo R.

Anat Rec (Hoboken). 2010 Sep;293(9):1506-11. doi: 10.1002/ar.21202.

4.

Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.

Lee S, Cho NY, Choi M, Yoo EJ, Kim JH, Kang GH.

Pathol Int. 2008 Feb;58(2):104-13. doi: 10.1111/j.1440-1827.2007.02197.x.

PMID:
18199160
5.

Influence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma.

Rose JS, Serna DS, Martin LK, Li X, Weatherby LM, Abdel-Misih S, Zhao W, Bekaii-Saab T.

Cancer. 2012 Dec 15;118(24):6243-52. doi: 10.1002/cncr.27666. Epub 2012 Jun 6.

6.

[Correlation between KRAS mutations and clinicopathologic features in colorectal carcinomas].

Gao J, Zhang J, Lu T, Li XY, Jia N, Liang ZY.

Zhonghua Bing Li Xue Za Zhi. 2012 Sep;41(9):595-8. doi: 10.3760/cma.j.issn.0529-5807.2012.09.005. Chinese.

PMID:
23157826
7.

A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer.

Smits KM, Paranjape T, Nallur S, Wouters KA, Weijenberg MP, Schouten LJ, van den Brandt PA, Bosman FT, Weidhaas JB, van Engeland M.

Clin Cancer Res. 2011 Dec 15;17(24):7723-31. doi: 10.1158/1078-0432.CCR-11-0990. Epub 2011 Oct 12.

8.

[Mutations of KRAS and BRAF in Chinese patients with colorectal carcinoma: analyses of 966 cases].

Gao J, Sun ZW, Li YY, Shen L.

Zhonghua Bing Li Xue Za Zhi. 2012 Sep;41(9):579-83. doi: 10.3760/cma.j.issn.0529-5807.2012.09.002. Chinese.

PMID:
23157823
9.

BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy.

Teng HW, Huang YC, Lin JK, Chen WS, Lin TC, Jiang JK, Yen CC, Li AF, Wang HW, Chang SC, Lan YT, Lin CC, Wang HS, Yang SH.

J Surg Oncol. 2012 Aug 1;106(2):123-9. doi: 10.1002/jso.23063. Epub 2012 Feb 13.

PMID:
22331825
10.

Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.

Abubaker J, Bavi P, Al-Haqawi W, Sultana M, Al-Harbi S, Al-Sanea N, Abduljabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Uddin S, Al-Kuraya KS.

J Pathol. 2009 Dec;219(4):435-45. doi: 10.1002/path.2625.

PMID:
19824059
11.

Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability.

Umeda Y, Nagasaka T, Mori Y, Sadamori H, Sun DS, Shinoura S, Yoshida R, Satoh D, Nobuoka D, Utsumi M, Yoshida K, Yagi T, Fujiwara T.

J Hepatobiliary Pancreat Sci. 2013 Feb;20(2):223-33. doi: 10.1007/s00534-012-0531-9.

PMID:
23010994
12.

[KRAS and BRAF gene mutations in correlation with clinicopathologic features of colorectal carcinoma in Chinese].

Zhu XL, Cai X, Zhang L, Yang F, Sheng WQ, Lu YM, Du X, Zhou XY.

Zhonghua Bing Li Xue Za Zhi. 2012 Sep;41(9):584-9. doi: 10.3760/cma.j.issn.0529-5807.2012.09.003. Chinese.

PMID:
23157824
13.

[Correlation of KRAS gene mutations and clinicopathologic parameters in colorectal carcinoma].

Wang Q, Zhong M, Lü YL, Yuan J, Wei LX.

Zhonghua Bing Li Xue Za Zhi. 2012 Sep;41(9):603-6. doi: 10.3760/cma.j.issn.0529-5807.2012.09.007. Chinese.

PMID:
23157828
14.

Acquired KRAS mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosis.

Bouchahda M, Karaboué A, Saffroy R, Innominato P, Gorden L, Guettier C, Adam R, Lévi F.

Cancer Chemother Pharmacol. 2010 Aug;66(3):605-9. doi: 10.1007/s00280-010-1298-9. Epub 2010 Apr 2.

PMID:
20361188
15.

KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis.

Cejas P, López-Gómez M, Aguayo C, Madero R, de Castro Carpeño J, Belda-Iniesta C, Barriuso J, Moreno García V, Larrauri J, López R, Casado E, Gonzalez-Barón M, Feliu J.

PLoS One. 2009 Dec 18;4(12):e8199. doi: 10.1371/journal.pone.0008199.

16.

Somatic gene mutations in African Americans may predict worse outcomes in colorectal cancer.

Kang M, Shen XJ, Kim S, Araujo-Perez F, Galanko JA, Martin CF, Sandler RS, Keku TO.

Cancer Biomark. 2013;13(5):359-66. doi: 10.3233/CBM-130366.

PMID:
24440976
17.

KRAS mutations in patients with colorectal cancer as detected by high-resolution melting analysis and direct sequencing.

Akiyoshi K, Yamada Y, Honma Y, Iwasa S, Kato K, Hamaguchi T, Shimada Y, Taniguchi H, Furuta K.

Anticancer Res. 2013 May;33(5):2129-34.

PMID:
23645765
18.
19.

KRAS mutation correlates with accelerated metastatic progression in patients with colorectal liver metastases.

Nash GM, Gimbel M, Shia J, Nathanson DR, Ndubuisi MI, Zeng ZS, Kemeny N, Paty PB.

Ann Surg Oncol. 2010 Feb;17(2):572-8. doi: 10.1245/s10434-009-0605-3. Epub 2009 Sep 1.

PMID:
19727962
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk